Akari Therapeutics, Plc (AKTX)
Largest Insider Buys in Sector
AKTX Stock Price History Chart
AKTX Stock Performance
About Akari Therapeutics, Plc
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.
Insider Activity of Akari Therapeutics, Plc
Over the last 12 months, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of Akari Therapeutics, Plc stock.
On average, over the past 5 years, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,055,600 shares for transaction amount of $200,036 was made by Cohen Mark S (director) on 2015‑09‑18.
List of Insider Buy and Sell Transactions, Akari Therapeutics, Plc
| 2015-09-18 | Cohen Mark S | director | 1.06M 0.0711% | $0.19 | $200,036 | -56.76% | ||
| 2014-04-15 | SABBY MANAGEMENT, LLC | 10 percent owner | 17,100 0.3007% | $5.00 | $85,500 | +9.59% | ||
| 2014-04-14 | SABBY MANAGEMENT, LLC | 10 percent owner | 3,000 0.0539% | $5.21 | $15,630 | +7.49% | ||
| 2014-04-11 | SABBY MANAGEMENT, LLC | 10 percent owner | 100 0.0017% | $5.15 | $515 | +3.70% | ||
| 2014-04-10 | SABBY MANAGEMENT, LLC | 10 percent owner | 1,400 0.0252% | $5.25 | $7,350 | +6.67% | ||
| 2014-04-09 | SABBY MANAGEMENT, LLC | 10 percent owner | 1,075 0.0194% | $5.51 | $5,923 | +1.82% | ||
| 2014-04-08 | SABBY MANAGEMENT, LLC | 10 percent owner | 35,500 0.6218% | $5.36 | $190,280 | +1.82% | ||
| 2014-04-07 | SABBY MANAGEMENT, LLC | 10 percent owner | 20,654 0.3716% | $5.71 | $117,840 | -1.75% | ||
| 2014-04-04 | SABBY MANAGEMENT, LLC | 10 percent owner | 12,250 0.216% | $6.07 | $74,400 | -9.53% | ||
| 2014-04-02 | SABBY MANAGEMENT, LLC | 10 percent owner | 2,500 0.0441% | $6.15 | $15,375 | -10.69% | ||
| 2014-04-01 | SABBY MANAGEMENT, LLC | 10 percent owner | 15,371 0.2742% | $6.10 | $93,806 | -8.94% | ||
| 2014-03-31 | SABBY MANAGEMENT, LLC | 10 percent owner | 7,936 0.1396% | $6.35 | $50,394 | -13.63% | ||
| 2014-03-27 | SABBY MANAGEMENT, LLC | 10 percent owner | 1,700 0.0344% | $6.61 | $11,237 | -14.92% | ||
| 2014-03-26 | SABBY MANAGEMENT, LLC | 10 percent owner | 14,200 0.2876% | $6.66 | $94,619 | -15.34% | ||
| 2014-03-25 | SABBY MANAGEMENT, LLC | 10 percent owner | 303 0.0061% | $6.90 | $2,091 | -18.99% | ||
| 2014-03-24 | SABBY MANAGEMENT, LLC | 10 percent owner | 2,400 0.0465% | $6.71 | $16,104 | -19.43% | ||
| 2014-03-21 | SABBY MANAGEMENT, LLC | 10 percent owner | 4,900 0.1002% | $6.83 | $33,467 | -16.36% | ||
| 2014-03-20 | SABBY MANAGEMENT, LLC | 10 percent owner | 3,800 0.0768% | $6.90 | $26,220 | -18.12% | ||
| 2014-03-17 | SABBY MANAGEMENT, LLC | 10 percent owner | 2,400 0.0479% | $6.65 | $15,960 | -16.17% |